Huma.AI
PrivateLast Round
Series A
Feb 7, 2022
Total Funding Raised
$11.93M
Company Overview
Huma.AI operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Series A round in February 2022.
Huma.AI is a healthcare technology company that provides a generative AI-powered knowledge automation platform to help life sciences and pharmaceutical teams extract insights from unstructured data.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Compliance & Risk, NLP & Conversational AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Huma.AI Comparables
Compare Huma.AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorcero | 92% | |
| Atrix AI | 88% | |
| Flinn.ai | 81% |
For institutional investors. Book with your work email.
Huma.AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 7, 2022 | ||||
| Grant | Nov 16, 2021 | ||||
| Grant | Jul 22, 2021 | ||||
| Seed | Oct 7, 2019 |
For institutional investors. Book with your work email.
Huma.AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Series A, Seed |
| SteelSky Ventures | Series A |
| Hatteras Venture Partners | Series A |
| Boston Millennia Partners | Series A |
| A/O PropTech | Seed |
| Excelerate Health Ventures | Series A |
| ShangBay Capital | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 7, 2022
$9.5M round led by Excelerate Health Ventures.
- Oct 7, 2019
$2.4M round led by A/O PropTech, Fusion Fund, and ShangBay Capital.
For institutional investors. Book with your work email.
Huma.AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Huma.AI's valuation, stock price, and market status.
Is Huma.AI a public or private company?
Huma.AI is a private company.
What is the current stock price of Huma.AI?
Huma.AI is a private company, so its shares have no public market price. Caplight tracks Huma.AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Huma.AI worth (valuation)?
Valuation information for Huma.AI is not publicly available.
Can I buy Huma.AI stock?
Huma.AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Huma.AI's last funding round?
Huma.AI's most recent funding round was Series A on February 7, 2022.
Who are the main investors in Huma.AI?
Key investors in Huma.AI include Excelerate Health Ventures.
Will Huma.AI IPO soon?
No public IPO plans have been announced for Huma.AI.
How can I track Huma.AI secondary market activity?
Caplight tracks bids, offers, and trades in Huma.AI's shares on secondary markets.